TERMINALLY MODIFIED RNA

Abstract: the invention relates to compositions and methods for the manufacture and optimization of modified mrna molecules via optimization of their terminal architecture.

Inventor(s): Tirtha CHAKRABORTY, Stephane BANCEL, Stephen G. HOGE, Atanu ROY, Antonin DE FOUGEROLLES, Noubar B. AFEYAN

CPC Classification: A61K39/00 (Medicinal preparations containing antigens or antibodies (materials for immunoassay ))

Search for rejections for patent application number 20250170228